News

Latest news

5th October 2021

Sequana Medical announces FDA approval to expand patient enrolment in North American pivotal alfapump® study (POSEIDON)

Read more
29th September 2021

ACTICOR BIOTECH announces its projected IPO on the Euronext Growth® market in Paris

Read more
10th September 2021

ニュートン・バイオキャピタル、株式会社PRISM BioLabに新規投資

Read more
9th September 2021

Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

Read more
2nd July 2021

ニュートン・バイオキャピタル、エディットフォース株式会社に追加投資

Read more
1st July 2021

Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology

Read more
22nd June 2021

Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

Read more
15th June 2021

Acticor Biotech Announces appointment of Mr Alain Munoz as Chairman of the Board of Directors and Mrs Sophie Binay and Mr Yannick Pletan as General Managers.

Read more
29th March 2021

Sequana Medical Announces New Share Capital Amount and New Number of Shares

Read more